Syra Health To Discuss Fourth Quarter and Full Year 2024 Financial Results
Conference call will be held on Tuesday, March 11 at 9:00 a.m. ET CARMEL, Ind., March 4, 2025 /PRNewswire/ --...
Mental Health
WELL Health Provides Corporate Update Highlighting Canadian Clinics Growth Momentum and Record Pipeline of Canadian Public Sector Business Opportunities Amidst Surge of ‘Buy Canadian’ Sentiment
WELL announces it has added 11 clinics to its Canadian Clinics network since February 1, 2025. This included 9 acquired...
Foresight Psychology Launches Cutting Edge and Comprehensive Yet Affordable Psychological Testing Nationwide
Advanced Testing with a Reduced Wait Time SAN DIEGO, March 3, 2025 /PRNewswire/ -- Foresight Psychology, a leading provider of...
ABM of PPC Inc. Unveils the World’s First Emotion Processing Unit (EPU) Chip: A 10 Trillion dollar Industry Disruptor Transforming Neuroscience, Mental Health, Military Strategy & Human Performance
Boston, March 3, 2025 /PRNewswire/ -- Advanced Brain Methodologies Inc. (ABM) a division of Primary & Preventive Care Inc., has...
Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders
Patent Strengthens Nexalin’s Intellectual Property Portfolio and Highlights the Potential of DIFS™ Technology in Addressing Substance Use Disorders, Including Opioids,...
Revive Therapeutics Announces LOI to Acquire DiagnaMed’s Molecular Hydrogen Program
TORONTO, March 03, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a...
Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025
- Greatly improved patient quality of life and reduced disease impact in patients with CSU and CIndU -- 82% of...
Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval
HALO™ Clarity Devices Successfully Shipped for First Phase of Clinical TrialsHOUSTON, TX, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology,...
Novartis oral Fabhalta® (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)
If approved, Fabhalta® will be the only medicine indicated to selectively target the underlying cause of C3G1, an ultra-rare, progressive kidney...
Nxera Pharma Enters Agreement with Holling to Commercialize Daridorexant in Taiwan
Daridorexant is a potential best-in-class treatment in the high-growth, dual orexin antagonist class of medicines treating sleep disorders, such as...
Lime AI Debuts at MWC 2025: A Game-Changer in Stress Management
SEOUL, South Korea, Feb. 28, 2025 /PRNewswire/ -- BlueSignum, the innovator behind DailyBean, is set to launch its latest breakthrough in...
OpenText to Showcase New Innovations to Empower Healthcare Providers at HIMSS 2025
WATERLOO, ON, Feb. 27, 2025 /PRNewswire/ -- OpenText™ (NASDAQ: OTEX), (TSX: OTEX) will showcase its industry-leading ability to deliver secure communications, streamlined...
Unite Us Receives Grant to Combat Ohio’s Opioid Crisis and Expand Recovery Services in Montgomery County
Funding from OneOhio Recovery Foundation will drive technology-enabled recovery services and increase access to critical support for Ohioans impacted by...
Awakn Life Sciences Enters into Arrangement Agreement for The Acquisition of Awakn by Solvonis Therapeutics plc
Toronto, Ontario--(Newsfile Corp. - February 27, 2025) - Awakn Life Sciences Corp. (CSE: AWKN) (OTC Pink: AWKNF) (FSE: 954) ("Awakn"...
Ellucian Foundation Awards $600,000+ in PATH Scholarships to 47 Colleges and Universities Globally to Support Student Financial Success
Progress, Accomplishment, Thriving, Hope (PATH) scholarships address financial stressors affecting student mental health, retention and academic performance RESTON, Va., Feb....
HIMSS25: FDB to Spotlight Customer Success Stories and Innovative Drug Knowledge Solutions
From Integrating Real-Time Pharmacogenomics to Boosting Medication Adherence, Healthcare Organizations Are Realizing the Benefits of Advanced Medication Decision Support SOUTH...
Aura Unites with Boston Children’s Hospital to Address the Role of Technology in the Crisis of Wellbeing Among American Children
This collaboration aims to give parents and families the tools and resources they need to live safe, balanced online lives....
Venus Williams Invests in WeWard App to Promote a Healthier World Through Walking
Tennis champion and entrepreneur Venus Williams joins walking app WeWard as an investor and ambassador. NEW YORK, Feb. 26, 2025 /PRNewswire/...
ONE Retreats’ Transformative Psilocybin Wellness Initiative Addresses Mental Health Conditions for Veterans
SEAL Future Foundation joins forces to expand safe access to psychedelic-assisted therapies “Guidance Integration Platform” to provide integration resources for...
Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board
HOUSTON, TX, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader...